Sunil Kohli
Overview
Explore the profile of Sunil Kohli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roy M, Majid H, Khan P, Sharma N, Kohli S, Islam S, et al.
J Diabetes Metab Disord
. 2024 Nov;
23(2):2055-2064.
PMID: 39610562
Objective: Type 2 diabetes mellitus (T2DM) demonstrates a higher risk of fractures compared to the healthy population. Therefore, the aim of our study is to assess the risk of osteoporosis...
2.
Kulkarni P, Kawade A, Kohli S, Munshi R, Maliye C, Gogtay N, et al.
Lancet Infect Dis
. 2024 Nov;
PMID: 39521012
Background: Meningococcal disease remains an important public health problem globally. We assessed the non-inferiority and the lot-to-lot consistency of a pentavalent meningococcal ACYWX conjugate vaccine (NmCV-5; Serum Institute of India,...
3.
Sharma T, Goyal B, Ahmed K, Deo G, Kaushik I, Malik R, et al.
Int J Yoga
. 2024 Oct;
17(2):124-131.
PMID: 39444676
Background: Hypothyroidism is an endocrine disorder in which the thyroid gland does not produce an adequate amount of thyroid hormones. This study aimed to determine the efficacy of yoga asanas...
4.
Shaik A, Kohli S, Vohora D
Diabetes Res Clin Pract
. 2024 Jun;
213:111744.
PMID: 38878869
Aims: The skeletal effects of metformin monotherapy and in combination with teneligliptin are not well illustrated in patients with T2DM. To address this, we conducted an observational study to evaluate...
5.
Kulkarni P, Gunale B, Kohli S, Lalwani S, Tripathy S, Kar S, et al.
Sci Rep
. 2023 Oct;
13(1):16579.
PMID: 37789040
Due to waning immunity following primary immunization with COVID-19 vaccines, booster doses may be required. The present study assessed a heterologous booster of SII-NVX-CoV2373 (spike protein vaccine) in adults primed...
6.
Gunale B, Kapse D, Kar S, Bavdekar A, Kohli S, Lalwani S, et al.
JAMA Pediatr
. 2023 Jul;
PMID: 37523166
Importance: The recombinant COVID-19 vaccine NVX-CoV2373 has demonstrated efficacy of approximately 90% in adults; however, its safety and efficacy in children is unknown. Objective: To assess the noninferiority of SII-NVX-CoV2373...
7.
Jain V, Nabi N, Aggarwal S, Alam Z, Chandra K, Singh D, et al.
J Clin Nurs
. 2023 Feb;
33(1):115-125.
PMID: 36802108
Objectives: To determine post-COVID syndromes in the Indian population, correlating a wide spectrum of post-COVID manifestations with acute disease severity and associated risk factors. Background: Post-COVID Syndrome (PCS) is defined...
8.
Kulkarni P, Kadam A, Godbole S, Bhatt V, Raut A, Kohli S, et al.
Lancet Reg Health Southeast Asia
. 2023 Jan;
10:100139.
PMID: 36647543
Background: NVX-CoV2373, a Covid-19 vaccine was developed in the USA with ∼90% efficacy. The same vaccine is manufactured in India after technology transfer (called as SII-NVX-CoV2373), was evaluated in this...
9.
Puri R, Mehta V, Duell P, Wangnoo S, Rastogi A, Mohan V, et al.
J Clin Lipidol
. 2022 Dec;
17(2):e1-e14.
PMID: 36577628
In 2021 an estimated 74 million individuals had diabetes in India, almost all type 2 diabetes. More than half of patients with diabetes are estimated to be undiagnosed and more...
10.
Athar M, Garg A, Khan M, Parveen R, Kohli S, Vohora D, et al.
Int J Clin Pharmacol Ther
. 2022 Dec;
61(3):102-110.
PMID: 36519927
Background: Various studies have reported the association of cognition and depression with diabetes. Literature suggests that metformin and sitagliptin used to control hyperglycemia in type 2 diabetes mellitus (T2DM) possess...